Telomir Pharmaceuticals, Inc. Common Stock
Financial ratios & Valuation

Historical Multiples (2021 – 2023)

2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.50K-242.66-15.85N/A-242.66
Price/Sales ratio
N/AN/AN/AN/AN/A
Price/Book Value ratio
-1.50K-221.1360.28N/A-221.13
Price/Cash Flow ratio
-1.73K-442.25-53.69N/A-442.25
Price/Free Cash Flow ratio
-1.73K-442.25-53.69N/A-442.25
Price/Earnings Growth ratio
N/A-0.47-0.01N/A-0.47
Dividend Yield
N/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/A
Effective Tax Rate
100.00%99.99%N/AN/A99.99%
Return on Assets
N/A-1752.81%-273.82%N/A-1752.81%
Return On Equity
100%91.13%-380.19%N/A91.13%
Return on Capital Employed
100%91.13%-114.65%N/A91.13%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/A
Quick Ratio
N/A0.040.32N/A0.04
Cash ratio
N/A0.000.00N/A0.00
Days of Sales Outstanding
N/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/A65.47N/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/A11.930.02N/A11.93
Debt Equity Ratio
-0.86-0.620.02N/A-0.62
Long-term Debt to Capitalization
N/AN/AN/AN/AN/A
Total Debt to Capitalization
-6.37-1.630.02N/A-1.63
Interest Coverage Ratio
N/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
-1-0.80-38.21N/A-0.80
Company Equity Multiplier
N/A-0.051.38N/A-0.05
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
111N/A1
Cash Flow Coverage Ratio
-1-0.80-38.21N/A-0.80
Short Term Coverage Ratio
-1-0.80-38.21N/A-0.80
Dividend Payout Ratio
N/AN/AN/AN/AN/A